MeSH term
Frequency | Condition_Probility | Female | 3 | 0.0 |
Humans | 16 | 0.0 |
Research Support, Non-U.S. Gov't | 10 | 0.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Animals | 7 | 0.0 |
Cell Division | 2 | 0.0 |
Cell Line | 4 | 0.0 |
Gene Expression | 2 | 0.0 |
Mice | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Transfection | 2 | 0.0 |
Gene Expression Profiling/methods | 2 | 2.0 |
Tetracycline/pharmacology | 2 | 2.0 |
U937 Cells | 2 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Base Sequence | 3 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Blotting, Western | 3 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
*Phosphoproteins | 6 | 4.0 |
Protein p53/*metabolism | 3 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
RNA, Small Interfering/metabolism | 2 | 1.0 |
Time Factors | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Cell Cycle | 2 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Hematopoiesis/*genetics | 2 | 3.0 |
Interferon-gamma, Recombinant/pharmacology | 2 | 1.0 |
Male | 2 | 0.0 |
*Nuclear Proteins | 5 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
